1. Home
  2. RCUS vs EXG Comparison

RCUS vs EXG Comparison

Compare RCUS & EXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$24.31

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Logo Eaton Vance Tax-Managed Global Diversified Equity Income Fund of Beneficial Interest

EXG

Eaton Vance Tax-Managed Global Diversified Equity Income Fund of Beneficial Interest

HOLD

Current Price

$9.60

Market Cap

2.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCUS
EXG
Founded
2015
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.9B
IPO Year
2018
2006

Fundamental Metrics

Financial Performance
Metric
RCUS
EXG
Price
$24.31
$9.60
Analyst Decision
Buy
Analyst Count
10
0
Target Price
$31.90
N/A
AVG Volume (30 Days)
1.0M
437.5K
Earning Date
05-05-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$247,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$45.62
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.92
$8.25
52 Week High
$28.72
$9.78

Technical Indicators

Market Signals
Indicator
RCUS
EXG
Relative Strength Index (RSI) 52.04 57.01
Support Level $23.91 $9.46
Resistance Level $24.33 $9.72
Average True Range (ATR) 1.45 0.13
MACD 0.04 0.00
Stochastic Oscillator 57.31 83.12

Price Performance

Historical Comparison
RCUS
EXG

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

About EXG Eaton Vance Tax-Managed Global Diversified Equity Income Fund of Beneficial Interest

Eaton Vance Tax-Mgd Glbl Div Eq Inc is a diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary focus of the fund is capital appreciation. It invests in a diversified portfolio of domestic and foreign common stocks, emphasizing dividend-paying stocks. It writes call options on one or more U.S. and foreign indices for a portion of the value of its common stock portfolio to generate current cash flow from the options premium received. Its portfolio of investments consists of capital markets, banks, internet and direct marketing retail, biotechnology, media, oil, gas, consumable fuels, and other sectors.

Share on Social Networks: